Bluebird Bio Advances Experimental Drug for Genetic Brain Disorder

Bluebird bio advances experimental drug for genetic brain disorder
Bluebird bio Inc., a Cambridge gene therapy company that had an intial public stock offering in June, said Monday the first patient has has undergone infusion with bluebird bio's Lenti-D drug product in a stem cell transplantation. … the recent …
Read more on Boston.com (blog)

Cholesterol Drugs May Boost Your Gums' Health, Too
In our study, benefits in the gums correlated with benefits in the arteries," said the study's senior author, Dr. Ahmed Tawakol, co-director of the Cardiac Imaging Trials Program at Massachusetts General Hospital and Harvard Medical School in Boston …
Read more on Philly.com

Bioidenticals no safer than other hormone replacement therapy
Some hormone products promoted as being bioidentical are Food and Drug Administration-approved, but that is not the case when a patient asks for a custom blend that has to be made at a compounding pharmacy. More from Morning Rounds with Dr. LaPook …
Read more on CBS News

Turning yellow – diagnosed.
Dr. Edward Ryan, the director of Tropical Medicine at Massachusetts General Hospital, led the infectious disease team that consulted on Jean's case. … The federal Centers for Disease Control and Prevention's website (http://wwwnc.cdc.gov/travel …
Read more on Boston.com

More Drug Treatment Centers In Massachusetts Information…